App-Quantinova.ai

Dynamic and immunocytochemistry analysis of circulation tumor cells (CTCs) in blood samples from patients with advanced ccRCC starting first-line treatment in a Brazilian Cancer Center.

Milena Shizue Tariki - American Society of Clinical Oncology Genitourinary (ASCO GU) , 2023

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Evaluating the clinical utility of circulating tumor cells (CTC) profiling to predict selection of preferred therapeutic regimens in newly diagnosed or pretreated refractory renal cell carcinomas (RCC).

Ulka N. Vaishampayan - American Society of Clinical Oncology Genitourinary (ASCO GU) , 2023

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Renal cell carcinoma

N/A

3D rectal water-contrast transvaginal ultrasonography versus CT colonography for estimating bowel stenosis due to rectosigmoid endometriosis

F. Barra - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Endometriosis

N/A

Clinical and pharmacodynamic biomarker results from PORTER, a multi-cohort phase 1 platform trial of combination immunotherapy for metastatic castration-resistant prostate cancer patients

Matthew Galsky - American Society of Clinical Oncology (ASCO) Society for Immunotherapy of Cancer (SITC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Metastatic castration-resistant prostate cancer

Nivolumab

Does accelerated liver hypertrophy caused by the ALPPS procedure lead to circulating tumour cell dissemination in patients with colorectal liver metastases?

M.E. Tun-Abraham - International Hepato-Pancreato-Biliary Association (IHPBA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Colorectal liver metastases

N/A

Prognostic Role of Circulating Tumor Cells in Resectable Colorectal Liver Metastases

M. ROY - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Circulating Tumor Cells in Hepatocellular Carcinoma (HCC) and their Association with Early Recurrence after Surgery: A Preliminary Study

C. Ciulli - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

The Early Detection of Circulating Tumor Cells Using Telomerase-Selective Replicating Adenovirus in Pancreatic Cancer Patient

S. Irie - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreato-biliary malignancies

N/A

Feasibility of intraoperative CTC detection from portal vein during resection for pancreatic adenocarcinoma

A.J. Lee - International Hepato-Pancreato-Biliary Association (IHPBA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreatic cancer

N/A

Ligating the Corresponding Inflow and Outflow Vessels during Hepatectomy: A Prospective Randomized Controlled Trial and Animal Study

B. Zhang - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Improving accessibility to pancreatic cancer with circulating tumour cell technologies for targeted molecular therapeutics

C. Chew - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreatic cancer

N/A

Circulating Tumor Cells as a Tumor Stage Independent Biomarker for Diagnosis, Prognosis, and Disease-monitoring in Pancreatic Ductal Adenocarcinoma

C. Nitschke - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreas ductal adenocarcinoma

N/A

Early HCC Recurrence after Surgery and Circulating Tumor Cells Expression Pattern after Liquid Biopsy. A Preliminary Study

F. Carissimi - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Oncological Evaluation Using Circulating Tumor Cells and PET-CT of Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation

D. Ferreras - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

LEPTOMENINGEAL DISEASE SECONDARY TO MELANOMA: UPDATES ON THE VALIDITY OF THE VERIDEX CELLSEARCH SYSTEM

Yolanda Pina - Society for Neuro-Oncology (SNO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Leptomeningeal Metastasis

N/A

BEVACIZUMAB IN IDH WILD TYPE ADULT PATIENTS WITH RECURRENT GLIOBLASTOMA: A REAL WORD STUDY IN CHINA

Run Cui - Society for Neuro-Oncology (SNO) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Glioblastoma

Temozolomide

Bioinformatics Analysis of Gene Networks Associated with Glucose Variability and Inflammatory Pathways in Diabetes

OLGA V. SAIK - American Diabetes Association (ADA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Prognostic implication of portal venous circulating tumor cells in resectable pancreatic cancer

S. Yoon - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreato-biliary malignancies

N/A

Variant detection and personalized treatment in colorectal cancer

I. Papasotiriou - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Circulating tumor cell enumeration, biomarker analyses, and kinetics in patients with colorectal cancer and other GI malignancies

P. Kasi - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Filters

1671 Abstracts